Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia
There is growing evidence that immune/inflammatory processes are related to the etiology of schizophrenia. Danger-/damage-associated molecular patterns (DAMPs), also called alarmins, are recognized as inflammatory mediators that play an important role in the development of many infection-induced or...
Saved in:
Published in | Journal of psychiatric research Vol. 138; pp. 380 - 387 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | There is growing evidence that immune/inflammatory processes are related to the etiology of schizophrenia. Danger-/damage-associated molecular patterns (DAMPs), also called alarmins, are recognized as inflammatory mediators that play an important role in the development of many infection-induced or sterile inflammatory diseases. The importance of DAMPs particles in various mental disorders is still not clear. Therefore, this study aimed to evaluate serum levels of the most promising alarmins (IL-33, sST2, HMGB1, and S100B), as potent schizophrenia biomarkers. Sixty-eight adult patients with chronic schizophrenia and twenty-nine healthy volunteers were included in this prospective study. Enzyme-linked immunosorbent assay (ELISA) was used to assess the serum concentration of IL-33, sST2, HMGB1, and S100B. We documented that the serum levels of IL-33 (p = 0.006), sST2 (p = 0.02), HMGB1 (p = 0.01), and S100B (p = 0.04) are significantly higher in patients with schizophrenia than in healthy subjects. In male, but not in female, patients with schizophrenia, we found a significant difference in the serum IL-33, sST2, and HMGB1 concentrations as compared to the healthy men. In both male and female patients with schizophrenia, there was no significant difference in the serum concentrations of S100B in comparison to control subjects. In patients with schizophrenia, no significant correlations were noticed neither between any studied alarmins and PANSS scores nor between CDSS scores. Given that all investigated alarmins participate in the course of the neuroinflammatory process, they might be considered as biomarkers of neuroinflammatory process underlying schizophrenia. Based on our observations, it seems that the most useful biological indicator of schizophrenia would be IL-33. |
---|---|
AbstractList | There is growing evidence that immune/inflammatory processes are related to the etiology of schizophrenia. Danger-/damage-associated molecular patterns (DAMPs), also called alarmins, are recognized as inflammatory mediators that play an important role in the development of many infection-induced or sterile inflammatory diseases. The importance of DAMPs particles in various mental disorders is still not clear. Therefore, this study aimed to evaluate serum levels of the most promising alarmins (IL-33, sST2, HMGB1, and S100B), as potent schizophrenia biomarkers. Sixty-eight adult patients with chronic schizophrenia and twenty-nine healthy volunteers were included in this prospective study. Enzyme-linked immunosorbent assay (ELISA) was used to assess the serum concentration of IL-33, sST2, HMGB1, and S100B. We documented that the serum levels of IL-33 (p = 0.006), sST2 (p = 0.02), HMGB1 (p = 0.01), and S100B (p = 0.04) are significantly higher in patients with schizophrenia than in healthy subjects. In male, but not in female, patients with schizophrenia, we found a significant difference in the serum IL-33, sST2, and HMGB1 concentrations as compared to the healthy men. In both male and female patients with schizophrenia, there was no significant difference in the serum concentrations of S100B in comparison to control subjects. In patients with schizophrenia, no significant correlations were noticed neither between any studied alarmins and PANSS scores nor between CDSS scores. Given that all investigated alarmins participate in the course of the neuroinflammatory process, they might be considered as biomarkers of neuroinflammatory process underlying schizophrenia. Based on our observations, it seems that the most useful biological indicator of schizophrenia would be IL-33. There is growing evidence that immune/inflammatory processes are related to the etiology of schizophrenia. Danger-/damage-associated molecular patterns (DAMPs), also called alarmins, are recognized as inflammatory mediators that play an important role in the development of many infection-induced or sterile inflammatory diseases. The importance of DAMPs particles in various mental disorders is still not clear. Therefore, this study aimed to evaluate serum levels of the most promising alarmins (IL-33, sST2, HMGB1, and S100B), as potent schizophrenia biomarkers. Sixty-eight adult patients with chronic schizophrenia and twenty-nine healthy volunteers were included in this prospective study. Enzyme-linked immunosorbent assay (ELISA) was used to assess the serum concentration of IL-33, sST2, HMGB1, and S100B. We documented that the serum levels of IL-33 (p = 0.006), sST2 (p = 0.02), HMGB1 (p = 0.01), and S100B (p = 0.04) are significantly higher in patients with schizophrenia than in healthy subjects. In male, but not in female, patients with schizophrenia, we found a significant difference in the serum IL-33, sST2, and HMGB1 concentrations as compared to the healthy men. In both male and female patients with schizophrenia, there was no significant difference in the serum concentrations of S100B in comparison to control subjects. In patients with schizophrenia, no significant correlations were noticed neither between any studied alarmins and PANSS scores nor between CDSS scores. Given that all investigated alarmins participate in the course of the neuroinflammatory process, they might be considered as biomarkers of neuroinflammatory process underlying schizophrenia. Based on our observations, it seems that the most useful biological indicator of schizophrenia would be IL-33.There is growing evidence that immune/inflammatory processes are related to the etiology of schizophrenia. Danger-/damage-associated molecular patterns (DAMPs), also called alarmins, are recognized as inflammatory mediators that play an important role in the development of many infection-induced or sterile inflammatory diseases. The importance of DAMPs particles in various mental disorders is still not clear. Therefore, this study aimed to evaluate serum levels of the most promising alarmins (IL-33, sST2, HMGB1, and S100B), as potent schizophrenia biomarkers. Sixty-eight adult patients with chronic schizophrenia and twenty-nine healthy volunteers were included in this prospective study. Enzyme-linked immunosorbent assay (ELISA) was used to assess the serum concentration of IL-33, sST2, HMGB1, and S100B. We documented that the serum levels of IL-33 (p = 0.006), sST2 (p = 0.02), HMGB1 (p = 0.01), and S100B (p = 0.04) are significantly higher in patients with schizophrenia than in healthy subjects. In male, but not in female, patients with schizophrenia, we found a significant difference in the serum IL-33, sST2, and HMGB1 concentrations as compared to the healthy men. In both male and female patients with schizophrenia, there was no significant difference in the serum concentrations of S100B in comparison to control subjects. In patients with schizophrenia, no significant correlations were noticed neither between any studied alarmins and PANSS scores nor between CDSS scores. Given that all investigated alarmins participate in the course of the neuroinflammatory process, they might be considered as biomarkers of neuroinflammatory process underlying schizophrenia. Based on our observations, it seems that the most useful biological indicator of schizophrenia would be IL-33. |
Author | Kozłowska, Elżbieta Żelechowska, Paulina Wysokiński, Adam Brzezińska-Błaszczyk, Ewa Agier, Justyna |
Author_xml | – sequence: 1 givenname: Elżbieta surname: Kozłowska fullname: Kozłowska, Elżbieta email: elzbieta.kozlowska@umed.lodz.pl organization: Department of Experimental Immunology, Medical University of Lodz, Lodz, Poland – sequence: 2 givenname: Ewa surname: Brzezińska-Błaszczyk fullname: Brzezińska-Błaszczyk, Ewa organization: Department of Experimental Immunology, Medical University of Lodz, Lodz, Poland – sequence: 3 givenname: Justyna surname: Agier fullname: Agier, Justyna organization: Department of Experimental Immunology, Medical University of Lodz, Lodz, Poland – sequence: 4 givenname: Adam orcidid: 0000-0002-6159-6579 surname: Wysokiński fullname: Wysokiński, Adam organization: Department of Old Age Psychiatry and Psychotic Disorders, Medical University of Lodz, Lodz, Poland – sequence: 5 givenname: Paulina surname: Żelechowska fullname: Żelechowska, Paulina organization: Department of Experimental Immunology, Medical University of Lodz, Lodz, Poland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33957300$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkF1LIzEUQIO4rNXdvyB5dKEz3iTzkXmRteIXdFlY3eeQZu5g6jQZk6lQf72RKoJPfQpczj25nEOy77xDQiiDnAGrTpf5cogb82ADxpwDZzkUObBmj0yYrJuMibrZJxMAzjPRlNUBOYxxCQA1Z8V3ciDSsBYAE_LvvNdhZV2kJ7fzTIgpjXf3fEpv_lzP2JRq19I7BjD7RXWkgx_RjVb3dGH9SodHDJF2PtCYTnnxw0NAZ_UP8q3TfcSf7-8R-X91eX9xk83_Xt9enM8zU0g2Zl2pOZoSmgZ53RWgRVujNlK2rBasrljV8oWUmgkhSwOdrLisRAdNJ03VGhRH5GTrHYJ_WmMc1cpGg32vHfp1VLzkhah4Azyhx-_oerHCVg3BpvM36qNDAs62gAk-xoCdMnbUo_VuDNr2ioF6C6-W6jO8eguvoFApfBLIL4KPP3ZYnW1XMcV6thhUNBadwTahZlStt7tIfn-RmN46a3T_iJvdFK8eSbbS |
CitedBy_id | crossref_primary_10_2139_ssrn_4175654 crossref_primary_10_1016_j_neubiorev_2024_105949 crossref_primary_10_3390_ijms232113054 crossref_primary_10_1016_j_ejphar_2025_177469 crossref_primary_10_3390_medicina58060694 crossref_primary_10_1186_s43045_024_00395_9 crossref_primary_10_3390_brainsci13091334 crossref_primary_10_4081_itjm_2024_1830 crossref_primary_10_1007_s11126_024_10102_w crossref_primary_10_1016_j_jneuroim_2024_578466 crossref_primary_10_1007_s00406_023_01677_9 crossref_primary_10_1038_s41398_023_02490_7 crossref_primary_10_3389_fncel_2023_1163764 crossref_primary_10_3389_fpsyt_2023_1241422 crossref_primary_10_3390_ijms231911245 crossref_primary_10_1080_20473869_2023_2301185 crossref_primary_10_3389_fnins_2023_1243168 crossref_primary_10_33393_jcb_2021_2327 crossref_primary_10_1016_j_psychres_2022_114762 crossref_primary_10_1017_neu_2022_37 crossref_primary_10_3390_ijms24119413 crossref_primary_10_3389_fpsyt_2022_1024299 crossref_primary_10_3390_ijms24043402 crossref_primary_10_30773_pi_2022_0173 crossref_primary_10_1016_j_jneuroim_2022_577951 crossref_primary_10_1016_j_ajp_2023_103788 crossref_primary_10_2298_SARH220417081L |
Cites_doi | 10.3389/fimmu.2019.02536 10.9758/cpn.2019.17.2.244 10.1016/j.neulet.2009.06.019 10.1074/jbc.R400025200 10.3389/fncel.2020.00274 10.1002/jemt.10303 10.1016/j.imbio.2015.02.005 10.1007/978-3-211-98811-4_46 10.1159/000446825 10.1172/JCI62423 10.1186/s12974-020-01806-4 10.5455/jmood.20150929074204 10.1186/1476-9255-8-22 10.1038/sj.npp.1300403 10.1016/j.bbi.2017.10.025 10.30773/pi.2018.12.19.1 10.1016/S0022-3956(01)00003-6 10.1016/j.jneuroim.2019.576993 10.1016/j.jpsychires.2010.04.023 10.1093/schbul/sbx121 10.1111/imr.12577 10.1038/cmi.2016.34 10.1016/j.schres.2005.04.013 10.1073/pnas.1604032113 10.4110/in.2018.18.e27 10.1007/s12035-012-8264-y 10.3389/fimmu.2018.02379 10.2174/156652413804486214 10.3389/fncel.2019.00127 10.1016/j.jad.2013.12.042 10.1186/1742-2094-7-6 10.1155/2020/8465083 10.1007/s10072-018-3611-z 10.1515/bmc-2016-0026 10.1007/s12028-007-0008-x 10.1001/jamapsychiatry.2019.3360 10.1111/jnc.14574 10.1189/jlb.0306164 10.3389/fimmu.2017.00475 10.1093/gerona/glq004 10.3109/08039488.2014.984755 10.3389/fpsyt.2018.00271 10.1016/j.cytogfr.2019.05.009 10.1111/j.1471-4159.2011.07612.x 10.1016/j.comppsych.2019.152118 10.1038/srep27584 10.1016/j.nbd.2016.02.018 10.1155/2010/656481 10.1007/s00701-016-3046-3 10.1016/j.schres.2013.10.011 10.1016/j.comppsych.2017.01.008 10.1038/onc.2016.104 10.3389/fpsyt.2019.00892 10.1111/jnc.14450 10.1016/j.psychres.2008.01.002 10.4049/jimmunol.1601342 |
ContentType | Journal Article |
Copyright | 2021 The Author(s) Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
Copyright_xml | – notice: 2021 The Author(s) – notice: Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 |
DOI | 10.1016/j.jpsychires.2021.04.019 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-1379 |
EndPage | 387 |
ExternalDocumentID | 33957300 10_1016_j_jpsychires_2021_04_019 S0022395621002454 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29L 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM 9JO AABNK AADFP AAEDT AAEDW AAGJA AAGUQ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABIVO ABJNI ABLJU ABMAC ABMZM ABOYX ABPPZ ABWVN ABXDB ACDAQ ACGFS ACHQT ACIEU ACIUM ACNCT ACRLP ACRPL ACVFH ACXNI ADBBV ADCNI ADEZE ADMUD ADNMO ADXHL AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEG HF~ HMK HMO HMQ HMW HVGLF HZ~ IHE J1W K-O KOM L7B M29 M2V M39 M3V M41 MO0 MOBAO N9A O-L O9- OAUVE OH0 OKEIE OU- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SNS SPCBC SPS SSB SSH SSN SSY SSZ T5K WUQ YQT Z5R ZGI ~G- 6I. AACTN AADPK AAFTH AAIAV ABLVK ABYKQ AFCTW AFKWA AFYLN AJBFU AJOXV AMFUW EFLBG LCYCR RIG ZA5 AAYXX AGRNS CITATION NPM 7X8 |
ID | FETCH-LOGICAL-c481t-f5a2ec5099e27f40a3d7eac88d17317616d2b88a13385c0f862863f09f8c6dce3 |
IEDL.DBID | .~1 |
ISSN | 0022-3956 1879-1379 |
IngestDate | Fri Jul 11 16:32:35 EDT 2025 Mon Jul 21 05:33:58 EDT 2025 Tue Jul 01 01:04:00 EDT 2025 Thu Apr 24 22:57:53 EDT 2025 Fri Feb 23 02:46:13 EST 2024 Tue Aug 26 16:32:22 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Schizophrenia Biomarkers sST2 HMGB1 S100B IL-33 |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c481t-f5a2ec5099e27f40a3d7eac88d17317616d2b88a13385c0f862863f09f8c6dce3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-6159-6579 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0022395621002454 |
PMID | 33957300 |
PQID | 2524362902 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2524362902 pubmed_primary_33957300 crossref_citationtrail_10_1016_j_jpsychires_2021_04_019 crossref_primary_10_1016_j_jpsychires_2021_04_019 elsevier_sciencedirect_doi_10_1016_j_jpsychires_2021_04_019 elsevier_clinicalkey_doi_10_1016_j_jpsychires_2021_04_019 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-06-01 |
PublicationDateYYYYMMDD | 2021-06-01 |
PublicationDate_xml | – month: 06 year: 2021 text: 2021-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of psychiatric research |
PublicationTitleAlternate | J Psychiatr Res |
PublicationYear | 2021 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Rothermundt, Peters, Prehn, Arolt (bib46) 2003; 60 Kleindienst, Meissner, Eyupoglu, Parsch, Schmidt, Buchfelder (bib31) 2010; 106 Borsky, Fiala, Andrys, Beranek, Hamakova, Malkova, Svadlakova, Krejsek, Palicka, Borska, Rehacek (bib13) 2020; 2020 Franklin, Xu, Duman (bib24) 2018; 72 Santoro, Maetzler, Stathakos, Martin, Hobert, Rattay, Gasser, Forrester, Berg, Tracey, Riedel, Teismann (bib48) 2016; 91 Saresella, Marventano, Piancone, La Rosa, Galimberti, Fenoglio, Scarpini, Clerici (bib49) 2020; 17 Qi, Xiu, Chen, Wang, Kosten, Kosten, Zhang (bib42) 2009; 462 Wysokiński, Margulska, Strzelecki, Kłoszewska (bib58) 2015; 69 Chan, Roth, Oppenheim, Tracey, Vogl, Feldmann, Horwood, Nanchahal (bib15) 2012; 122 Hong, Zhao, Li, Peng, Wang, Li, Xiang, Su, Huang, Zhang, Zhao, Zhou, Mao, Lin, Fang, Zhang, Xie (bib28) 2016; 6 Trovão, Prata, VonDoellinger, Santos, Barbosam, Coelho (bib55) 2019; 16 Demir, Bulut, Kaya, Sevim, Demirpence, Ibiloglu, Gunes, Atli, Yasin (bib20) 2015; 5 Griesenauer, Paczesny (bib26) 2017; 8 Bertheloot, Latz (bib8) 2017; 14 Alsahebfosoul, Rahimmanesh, Shajarian, Etemadifar, Sedaghat, Hejazi, Naderi (bib2) 2017; 8 de Campos-Carli, Miranda, Dias, de Oliveira, Cruz, Vieira, Rocha, Barbosa, Salgado, Teixeira (bib19) 2017; 74 Comer, Carrier, Tremblay, Cruz-Martín (bib18) 2020; 14 Denning, Aziz, Gurien, Wang (bib21) 2019; 10 Al-Dujaili, Mousa, Al-Hakeim, Maes (bib1) 2020 Schmitt, Bertsch, Henning, Tost, Klimke, Henn, Falkai (bib50) 2005; 80 Barbosa, Morato, de Miranda, Bauer, Soares, Teixeira (bib7) 2014; 157 Zhu, Hu, Zhou, Qiao, Chang, Tong (bib62) 2019; 94 Zhu, Li, Hie, Yuan, Lü, Song (bib63) 2015; 95 Lu, Zhang, Barnie, Su (bib33) 2019; 47 Miller (bib38) 2011; 8 North, Bruggemann, Cropley, Swaminathan, Sundram, Lenroot, Pereira, Zalesky, Bousman, Pantelis, Weickert, Shannon Weickert (bib41) 2021; 24 Ye, Zeng, Jin, Zhang, Xiong, Gu (bib60) 2019; 13 Angelopoulou, Piperi, Papavassiliou (bib4) 2018; 146 Sorci, Bianchi, Riuzzi, Tubaro, Arcuri, Giambanco, Donato (bib52) 2010 Janoutová, Janácková, Serý, Zeman, Ambroz, Kovalová, Varechová, Hosák, Jirík, Janout (bib29) 2016; 37 Tourjman, Kouassi, Koué, Rocchetti, Fortin-Fournier, Fusar-Poli, Potvin (bib54) 2013; 151 Vocca, Di Sano, Uasuf, Sala, Riccobono, Gangemi, Albano, Bonanno, Gagliardo, Profita (bib56) 2015; 220 Fu, Hung, Yuen, Zhou, Mak, Chan, Cheung, Zhang, Fu, Liew, Ip (bib25) 2016; 113 Chen, He, Tu, Duan (bib17) 2020; 35 Lara, Gama, Belmonte-de-Abreu, Portela, Gonçalves, Fonseca, Hauck, Souza (bib32) 2001; 35 Momtazmanesh, Zare-Shahabadi, Rezaei (bib39) 2019; 10 McCutcheon, Reis Marques, Howes (bib35) 2020; 77 Rothermundt, Ponath, Glaserm, Hetzel, Arolt (bib47) 2004; 29 Black, Kushner, Samols (bib10) 2004; 279 Schroeter, Abdul-Khaliq, Krebs, Diefenbacher, Blasigm (bib51) 2009; 167 Hernandez, Huebener, Schwabe (bib27) 2016; 35 Donato, Cannon, Sorci (bib22) 2013; 13 Arora, Sagar, Mehta, Pallavi, Sharma, Mukhopadhyay (bib5) 2019; 61 Michetti, Corvino, Geloso, Lattanzi, Bernardini, Serpero, Gazzolo (bib36) 2012; 120 Marie-Claire, Courtin, Curis, Bouaziz-Amar, Laplanche, Jacob, Etain, Blanchard, Bellivier (bib34) 2019; 334 Chaves, Camozzato, Ferreira, Piazenski, Kochhann, Dall'Igna, Mazzini, Souza, Portela (bib16) 2010; 7 Baran, Bulut, Kaya, Demirpençe, Sevim, Akıl, Varol (bib6) 2019; 40 Rider, Voronov, Dinarello, Apte, Cohen (bib44) 2017; 198 Michetti, D'Ambrosi, Toesca, Puglisi, Serrano, Marchese, Corvino, Geloso (bib37) 2019; 148 Yang, Han, Oppenheim (bib59) 2017; 280 Thelin, Nelson, Bellander (bib53) 2017; 159 Bianchi (bib9) 2007; 81 Amarante-Mendes, Adjemian, Branco, Zanetti, Weinlich, Bortoluci (bib3) 2018; 9 Bruscia, Bonfield (bib14) 2016; 8 Borovcanin, Janicijevic, Jovanovic, Gajovic, Arsenijevic, Lukic (bib12) 2018; 9 Zhang, Xiu, Song, Chen, Wu, Haile, Kosten, Kosten (bib61) 2010; 44 Bloomfield, McKinney, Smith, Brisman (bib64) 2007; 6 Roh, Sohn (bib45) 2018; 18 Murray, Bhavsar, Tripoli, Howes (bib40) 2017; 43 Fang, Schachner, Shen (bib23) 2012; 45 Bolu, Aydın, Akgün, Coşkun, Garip, Öznur, Çelik, Uzun (bib11) 2019; 31 Willems, Trompet, Blauw, Westendorp, de Craen (bib57) 2010; 65 Karabulut, Taşdemir, Akcan, Küçükali, Tüzün, Çakır (bib30) 2019; 30 Trovão (10.1016/j.jpsychires.2021.04.019_bib55) 2019; 16 Michetti (10.1016/j.jpsychires.2021.04.019_bib37) 2019; 148 Saresella (10.1016/j.jpsychires.2021.04.019_bib49) 2020; 17 Sorci (10.1016/j.jpsychires.2021.04.019_bib52) 2010 Black (10.1016/j.jpsychires.2021.04.019_bib10) 2004; 279 Chaves (10.1016/j.jpsychires.2021.04.019_bib16) 2010; 7 Demir (10.1016/j.jpsychires.2021.04.019_bib20) 2015; 5 Griesenauer (10.1016/j.jpsychires.2021.04.019_bib26) 2017; 8 Schmitt (10.1016/j.jpsychires.2021.04.019_bib50) 2005; 80 Wysokiński (10.1016/j.jpsychires.2021.04.019_bib58) 2015; 69 Lara (10.1016/j.jpsychires.2021.04.019_bib32) 2001; 35 Zhang (10.1016/j.jpsychires.2021.04.019_bib61) 2010; 44 Barbosa (10.1016/j.jpsychires.2021.04.019_bib7) 2014; 157 Hernandez (10.1016/j.jpsychires.2021.04.019_bib27) 2016; 35 Vocca (10.1016/j.jpsychires.2021.04.019_bib56) 2015; 220 Arora (10.1016/j.jpsychires.2021.04.019_bib5) 2019; 61 Comer (10.1016/j.jpsychires.2021.04.019_bib18) 2020; 14 Bianchi (10.1016/j.jpsychires.2021.04.019_bib9) 2007; 81 Santoro (10.1016/j.jpsychires.2021.04.019_bib48) 2016; 91 Kleindienst (10.1016/j.jpsychires.2021.04.019_bib31) 2010; 106 Alsahebfosoul (10.1016/j.jpsychires.2021.04.019_bib2) 2017; 8 Michetti (10.1016/j.jpsychires.2021.04.019_bib36) 2012; 120 Ye (10.1016/j.jpsychires.2021.04.019_bib60) 2019; 13 Lu (10.1016/j.jpsychires.2021.04.019_bib33) 2019; 47 Zhu (10.1016/j.jpsychires.2021.04.019_bib63) 2015; 95 Momtazmanesh (10.1016/j.jpsychires.2021.04.019_bib39) 2019; 10 Qi (10.1016/j.jpsychires.2021.04.019_bib42) 2009; 462 Marie-Claire (10.1016/j.jpsychires.2021.04.019_bib34) 2019; 334 Hong (10.1016/j.jpsychires.2021.04.019_bib28) 2016; 6 Murray (10.1016/j.jpsychires.2021.04.019_bib40) 2017; 43 Chan (10.1016/j.jpsychires.2021.04.019_bib15) 2012; 122 Rothermundt (10.1016/j.jpsychires.2021.04.019_bib47) 2004; 29 Amarante-Mendes (10.1016/j.jpsychires.2021.04.019_bib3) 2018; 9 Chen (10.1016/j.jpsychires.2021.04.019_bib17) 2020; 35 Denning (10.1016/j.jpsychires.2021.04.019_bib21) 2019; 10 Schroeter (10.1016/j.jpsychires.2021.04.019_bib51) 2009; 167 Bloomfield (10.1016/j.jpsychires.2021.04.019_bib64) 2007; 6 Fang (10.1016/j.jpsychires.2021.04.019_bib23) 2012; 45 Borovcanin (10.1016/j.jpsychires.2021.04.019_bib12) 2018; 9 Zhu (10.1016/j.jpsychires.2021.04.019_bib62) 2019; 94 Janoutová (10.1016/j.jpsychires.2021.04.019_bib29) 2016; 37 de Campos-Carli (10.1016/j.jpsychires.2021.04.019_bib19) 2017; 74 Fu (10.1016/j.jpsychires.2021.04.019_bib25) 2016; 113 Bruscia (10.1016/j.jpsychires.2021.04.019_bib14) 2016; 8 Donato (10.1016/j.jpsychires.2021.04.019_bib22) 2013; 13 Baran (10.1016/j.jpsychires.2021.04.019_bib6) 2019; 40 Karabulut (10.1016/j.jpsychires.2021.04.019_bib30) 2019; 30 Willems (10.1016/j.jpsychires.2021.04.019_bib57) 2010; 65 North (10.1016/j.jpsychires.2021.04.019_bib41) 2021; 24 Rider (10.1016/j.jpsychires.2021.04.019_bib44) 2017; 198 Franklin (10.1016/j.jpsychires.2021.04.019_bib24) 2018; 72 McCutcheon (10.1016/j.jpsychires.2021.04.019_bib35) 2020; 77 Miller (10.1016/j.jpsychires.2021.04.019_bib38) 2011; 8 Tourjman (10.1016/j.jpsychires.2021.04.019_bib54) 2013; 151 Thelin (10.1016/j.jpsychires.2021.04.019_bib53) 2017; 159 Bertheloot (10.1016/j.jpsychires.2021.04.019_bib8) 2017; 14 Roh (10.1016/j.jpsychires.2021.04.019_bib45) 2018; 18 Yang (10.1016/j.jpsychires.2021.04.019_bib59) 2017; 280 Al-Dujaili (10.1016/j.jpsychires.2021.04.019_bib1) 2020 Bolu (10.1016/j.jpsychires.2021.04.019_bib11) 2019; 31 Angelopoulou (10.1016/j.jpsychires.2021.04.019_bib4) 2018; 146 Rothermundt (10.1016/j.jpsychires.2021.04.019_bib46) 2003; 60 Borsky (10.1016/j.jpsychires.2021.04.019_bib13) 2020; 2020 |
References_xml | – volume: 17 start-page: 174 year: 2020 ident: bib49 article-title: IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment publication-title: J. Neuroinflammation – volume: 9 start-page: 271 year: 2018 ident: bib12 article-title: IL-33/ST2 pathway and galectin-3 as a new analytes in pathogenesis and cardiometabolic risk evaluation in psychosis publication-title: Front. Psychiatr. – volume: 37 start-page: 1 year: 2016 end-page: 8 ident: bib29 article-title: Epidemiology and risk factors of schizophrenia publication-title: Neuroendocrinol. Lett. – volume: 6 start-page: 121 year: 2007 end-page: 138 ident: bib64 article-title: Reliability of S100B in predicting severity of central nervous system injury publication-title: Neurocrit. Care – volume: 148 start-page: 168 year: 2019 end-page: 187 ident: bib37 article-title: The S100B story: from biomarker to active factor in neural injury publication-title: J. Neurochem. – volume: 334 start-page: 576993 year: 2019 ident: bib34 article-title: Increased plasma levels of high mobility group box 1 protein in patients with bipolar disorder: a pilot study publication-title: J. Neuroimmunol. – volume: 61 start-page: 70 year: 2019 end-page: 76 ident: bib5 article-title: Serum S100B levels in patients with depression publication-title: Indian J. Psychiatr. – volume: 31 start-page: 244 year: 2019 end-page: 249 ident: bib11 article-title: Serum levels of high sensitivity C-reactive protein in drug-naïve first-episode psychosis and acute exacerbation of schizophrenia publication-title: Clin Psychopharmacol Neurosci – volume: 157 start-page: 41 year: 2014 end-page: 44 ident: bib7 article-title: A preliminary report of increased plasma levels of IL-33 in bipolar disorder: further evidence of pro-inflammatory status publication-title: J. Affect. Disord. – volume: 94 start-page: 152118 year: 2019 ident: bib62 article-title: Serum high-sensitivity C-reactive protein levels are positively associated with cognitive impairments in patients with first-episode schizophrenia publication-title: Compr. Psychiatr. – volume: 2020 start-page: 8465083 year: 2020 ident: bib13 article-title: Alarmins HMGB1, IL-33, S100A7, and S100A12 in psoriasis vulgaris publication-title: Mediat. Inflamm. – volume: 91 start-page: 59 year: 2016 end-page: 68 ident: bib48 article-title: In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin publication-title: Neurobiol. Dis. – year: 2010 ident: bib52 article-title: S100B protein, A damage-associated molecular pattern protein in the brain and heart, and beyond publication-title: Cardiovasc. Psychiatry. Neurol. – volume: 40 start-page: 167 year: 2019 end-page: 173 ident: bib6 article-title: High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease publication-title: Neurol. Sci. – volume: 10 start-page: 892 year: 2019 ident: bib39 article-title: Cytokine alterations in schizophrenia: an updated review publication-title: Front. Psychiatr. – volume: 122 start-page: 2711 year: 2012 end-page: 2719 ident: bib15 article-title: Alarmins: awaiting a clinical response publication-title: J. Clin. Invest. – volume: 462 start-page: 113 year: 2009 end-page: 117 ident: bib42 article-title: Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics publication-title: Neurosci. Lett. – volume: 81 start-page: 1 year: 2007 end-page: 5 ident: bib9 article-title: DAMPs, PAMPs and alarmins: all we need to know about danger publication-title: J. Leukoc. Biol. – volume: 220 start-page: 954 year: 2015 end-page: 963 ident: bib56 article-title: IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases publication-title: Immunobiology – volume: 47 start-page: 74 year: 2019 end-page: 82 ident: bib33 article-title: Dual faced HMGB1 plays multiple roles in cardiomyocyte senescence and cardiac inflammatory injury publication-title: Cytokine Growth Factor Rev. – volume: 8 start-page: 550 year: 2016 end-page: 563 ident: bib14 article-title: Cystic fibrosis lung immunity: the role of the macrophage publication-title: J. Innate. Immun. – volume: 60 start-page: 614 year: 2003 end-page: 632 ident: bib46 article-title: S100B in brain damage and neurodegeneration publication-title: Microsc. Res. Tech. – volume: 18 start-page: e27 year: 2018 ident: bib45 article-title: Damage-associated molecular patterns in inflammatory diseases publication-title: Immune. Netw. – volume: 95 start-page: 3818 year: 2015 end-page: 3822 ident: bib63 article-title: [Analysis of the changes of serum high mobility group protein B1 and cytokines in first-episode schizophrenia patients] publication-title: Zhonghua Yixue Zazhi – volume: 9 start-page: 2379 year: 2018 ident: bib3 article-title: Pattern recognition receptors and the host cell death molecular machinery publication-title: Front. Immunol. – volume: 106 start-page: 247 year: 2010 end-page: 250 ident: bib31 article-title: Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury publication-title: Acta Neurochir. Suppl. – volume: 35 start-page: 5931 year: 2016 end-page: 5941 ident: bib27 article-title: Damage-associated molecular patterns in cancer: a double-edged sword publication-title: Oncogene – volume: 35 start-page: 137 year: 2020 end-page: 146 ident: bib17 article-title: Dual immune functions of IL-33 in inflammatory bowel disease publication-title: Histol. Histopathol. – volume: 13 start-page: 24 year: 2013 end-page: 57 ident: bib22 article-title: Functions of S100 proteins publication-title: Curr. Mol. Med. – volume: 279 start-page: 48487 year: 2004 end-page: 48490 ident: bib10 article-title: C-reactive protein publication-title: J. Biol. Chem. – volume: 77 start-page: 201 year: 2020 end-page: 210 ident: bib35 article-title: Schizophrenia-an overview publication-title: JAMA. Psychiatry. – volume: 10 start-page: 2536 year: 2019 ident: bib21 article-title: DAMPs and NETs in sepsis publication-title: Front. Immunol. – volume: 24 year: 2021 ident: bib41 article-title: Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions publication-title: Eur. Arch. Psychiatr. Clin. Neurosci. – volume: 7 start-page: 6 year: 2010 ident: bib16 article-title: Serum levels of S100B and NSE proteins in Alzheimer's disease patients publication-title: J. Neuroinflammation – volume: 44 start-page: 1236 year: 2010 end-page: 1240 ident: bib61 article-title: Increased serum S100B in never-medicated and medicated schizophrenic patients publication-title: J. Psychiatr. Res. – volume: 8 start-page: 55 year: 2017 end-page: 60 ident: bib2 article-title: Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis publication-title: Biomol. Concepts – volume: 69 start-page: 346 year: 2015 end-page: 353 ident: bib58 article-title: Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder publication-title: Nord. J. Psychiatr. – volume: 120 start-page: 644 year: 2012 end-page: 659 ident: bib36 article-title: The S100B protein in biological fluids: more than a lifelong biomarker of brain distress publication-title: J. Neurochem. – volume: 14 start-page: 43 year: 2017 end-page: 64 ident: bib8 article-title: HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins publication-title: Cell. Mol. Immunol. – volume: 74 start-page: 96 year: 2017 end-page: 101 ident: bib19 article-title: Serum levels of interleukin-33 and its soluble form receptor (sST2) are associated with cognitive performance in patients with schizophrenia publication-title: Compr. Psychiatr. – volume: 8 start-page: 22 year: 2011 ident: bib38 article-title: Role of IL-33 in inflammation and disease publication-title: J. Inflamm. – volume: 29 start-page: 1004 year: 2004 end-page: 1011 ident: bib47 article-title: S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia publication-title: Neuropsychopharmacology – volume: 16 start-page: 177 year: 2019 end-page: 184 ident: bib55 article-title: Peripheral biomarkers for first-episode psychosis-opportunities from the neuroinflammatory hypothesis of schizophrenia publication-title: Psychiatry. Investig. – volume: 198 start-page: 1395 year: 2017 end-page: 1402 ident: bib44 article-title: Alarmins: feel the stress publication-title: J. Immunol. – volume: 65 start-page: 764 year: 2010 end-page: 768 ident: bib57 article-title: White blood cell count and C-reactive protein are independent predictors of mortality in the oldest old publication-title: J. Gerontol. A Biol. Sci. Med Sci. – volume: 146 start-page: 211 year: 2018 end-page: 218 ident: bib4 article-title: High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches publication-title: J. Neurochem. – volume: 8 start-page: 475 year: 2017 ident: bib26 article-title: The ST2/IL-33 Axis in immune cells during inflammatory diseases publication-title: Front. Immunol. – volume: 151 start-page: 43 year: 2013 end-page: 47 ident: bib54 article-title: Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis publication-title: Schizophr. Res. – volume: 14 start-page: 274 year: 2020 ident: bib18 article-title: The inflamed brain in schizophrenia: the convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation publication-title: Front. Cell. Neurosci. – volume: 113 start-page: E2705 year: 2016 end-page: E2713 ident: bib25 article-title: IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 72 start-page: 2 year: 2018 end-page: 13 ident: bib24 article-title: Depression and sterile inflammation: essential role of danger associated molecular patterns publication-title: Brain Behav. Immun. – volume: 13 start-page: 127 year: 2019 ident: bib60 article-title: The role of high mobility group box 1 in ischemic stroke publication-title: Front. Cell. Neurosci. – volume: 159 start-page: 209 year: 2017 end-page: 225 ident: bib53 article-title: A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury publication-title: Acta Neurochir. – volume: 30 start-page: 75 year: 2019 end-page: 81 ident: bib30 article-title: [Inflammation and neurodegeneration in patients with early-stageand chronic bipolar disorder] publication-title: Türk PsikiyatriDerg. – volume: 45 start-page: 499 year: 2012 end-page: 506 ident: bib23 article-title: HMGB1 in development and diseases of the central nervous system publication-title: Mol. Neurobiol. – volume: 280 start-page: 41 year: 2017 end-page: 56 ident: bib59 article-title: Alarmins and immunity publication-title: Immunol. Rev. – volume: 35 start-page: 11 year: 2001 end-page: 14 ident: bib32 article-title: Increased serum S100B protein in schizophrenia: a study in medication-free patients publication-title: J. Psychiatr. Res. – volume: 43 start-page: 1190 year: 2017 end-page: 1196 ident: bib40 article-title: 30 Years on: how the neurodevelopmental hypothesis of schizophrenia morphed into the developmental risk factor model of psychosis publication-title: Schizophr. Bull. – volume: 6 start-page: 27584 year: 2016 ident: bib28 article-title: Higher plasma S100B concentrations in schizophrenia patients, and dependently associated with inflammatory markers publication-title: Sci. Rep. – volume: 5 start-page: 145 year: 2015 ident: bib20 article-title: Increased high mobility group Box1 (HMGB1) level in major depressive disorder publication-title: J. Mood Disord. – year: 2020 ident: bib1 article-title: High mobility group protein 1 and dickkopf-related protein 1 in schizophrenia and treatment-resistant schizophrenia: associations with interleukin-6, symptom domains, and neurocognitive impairments publication-title: Schizophr. Bull. – volume: 167 start-page: 66 year: 2009 end-page: 72 ident: bib51 article-title: Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia--original research and meta-analysis publication-title: Psychiatr. Res. – volume: 80 start-page: 305 year: 2005 end-page: 313 ident: bib50 article-title: Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms publication-title: Schizophr. Res. – volume: 10 start-page: 2536 year: 2019 ident: 10.1016/j.jpsychires.2021.04.019_bib21 article-title: DAMPs and NETs in sepsis publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.02536 – volume: 31 start-page: 244 issue: 17 year: 2019 ident: 10.1016/j.jpsychires.2021.04.019_bib11 article-title: Serum levels of high sensitivity C-reactive protein in drug-naïve first-episode psychosis and acute exacerbation of schizophrenia publication-title: Clin Psychopharmacol Neurosci doi: 10.9758/cpn.2019.17.2.244 – volume: 462 start-page: 113 issue: 2 year: 2009 ident: 10.1016/j.jpsychires.2021.04.019_bib42 article-title: Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2009.06.019 – year: 2020 ident: 10.1016/j.jpsychires.2021.04.019_bib1 article-title: High mobility group protein 1 and dickkopf-related protein 1 in schizophrenia and treatment-resistant schizophrenia: associations with interleukin-6, symptom domains, and neurocognitive impairments publication-title: Schizophr. Bull. – volume: 279 start-page: 48487 year: 2004 ident: 10.1016/j.jpsychires.2021.04.019_bib10 article-title: C-reactive protein publication-title: J. Biol. Chem. doi: 10.1074/jbc.R400025200 – volume: 14 start-page: 274 year: 2020 ident: 10.1016/j.jpsychires.2021.04.019_bib18 article-title: The inflamed brain in schizophrenia: the convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation publication-title: Front. Cell. Neurosci. doi: 10.3389/fncel.2020.00274 – volume: 60 start-page: 614 issue: 6 year: 2003 ident: 10.1016/j.jpsychires.2021.04.019_bib46 article-title: S100B in brain damage and neurodegeneration publication-title: Microsc. Res. Tech. doi: 10.1002/jemt.10303 – volume: 24 year: 2021 ident: 10.1016/j.jpsychires.2021.04.019_bib41 article-title: Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions publication-title: Eur. Arch. Psychiatr. Clin. Neurosci. – volume: 220 start-page: 954 issue: 8 year: 2015 ident: 10.1016/j.jpsychires.2021.04.019_bib56 article-title: IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases publication-title: Immunobiology doi: 10.1016/j.imbio.2015.02.005 – volume: 61 start-page: 70 issue: 1 year: 2019 ident: 10.1016/j.jpsychires.2021.04.019_bib5 article-title: Serum S100B levels in patients with depression publication-title: Indian J. Psychiatr. – volume: 106 start-page: 247 year: 2010 ident: 10.1016/j.jpsychires.2021.04.019_bib31 article-title: Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury publication-title: Acta Neurochir. Suppl. doi: 10.1007/978-3-211-98811-4_46 – volume: 8 start-page: 550 issue: 6 year: 2016 ident: 10.1016/j.jpsychires.2021.04.019_bib14 article-title: Cystic fibrosis lung immunity: the role of the macrophage publication-title: J. Innate. Immun. doi: 10.1159/000446825 – volume: 122 start-page: 2711 issue: 8 year: 2012 ident: 10.1016/j.jpsychires.2021.04.019_bib15 article-title: Alarmins: awaiting a clinical response publication-title: J. Clin. Invest. doi: 10.1172/JCI62423 – volume: 17 start-page: 174 issue: 1 year: 2020 ident: 10.1016/j.jpsychires.2021.04.019_bib49 article-title: IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment publication-title: J. Neuroinflammation doi: 10.1186/s12974-020-01806-4 – volume: 5 start-page: 145 issue: 4 year: 2015 ident: 10.1016/j.jpsychires.2021.04.019_bib20 article-title: Increased high mobility group Box1 (HMGB1) level in major depressive disorder publication-title: J. Mood Disord. doi: 10.5455/jmood.20150929074204 – volume: 8 start-page: 22 issue: 1 year: 2011 ident: 10.1016/j.jpsychires.2021.04.019_bib38 article-title: Role of IL-33 in inflammation and disease publication-title: J. Inflamm. doi: 10.1186/1476-9255-8-22 – volume: 29 start-page: 1004 issue: 5 year: 2004 ident: 10.1016/j.jpsychires.2021.04.019_bib47 article-title: S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300403 – volume: 72 start-page: 2 year: 2018 ident: 10.1016/j.jpsychires.2021.04.019_bib24 article-title: Depression and sterile inflammation: essential role of danger associated molecular patterns publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2017.10.025 – volume: 35 start-page: 137 issue: 2 year: 2020 ident: 10.1016/j.jpsychires.2021.04.019_bib17 article-title: Dual immune functions of IL-33 in inflammatory bowel disease publication-title: Histol. Histopathol. – volume: 16 start-page: 177 issue: 3 year: 2019 ident: 10.1016/j.jpsychires.2021.04.019_bib55 article-title: Peripheral biomarkers for first-episode psychosis-opportunities from the neuroinflammatory hypothesis of schizophrenia publication-title: Psychiatry. Investig. doi: 10.30773/pi.2018.12.19.1 – volume: 35 start-page: 11 issue: 1 year: 2001 ident: 10.1016/j.jpsychires.2021.04.019_bib32 article-title: Increased serum S100B protein in schizophrenia: a study in medication-free patients publication-title: J. Psychiatr. Res. doi: 10.1016/S0022-3956(01)00003-6 – volume: 334 start-page: 576993 year: 2019 ident: 10.1016/j.jpsychires.2021.04.019_bib34 article-title: Increased plasma levels of high mobility group box 1 protein in patients with bipolar disorder: a pilot study publication-title: J. Neuroimmunol. doi: 10.1016/j.jneuroim.2019.576993 – volume: 44 start-page: 1236 issue: 16 year: 2010 ident: 10.1016/j.jpsychires.2021.04.019_bib61 article-title: Increased serum S100B in never-medicated and medicated schizophrenic patients publication-title: J. Psychiatr. Res. doi: 10.1016/j.jpsychires.2010.04.023 – volume: 43 start-page: 1190 issue: 6 year: 2017 ident: 10.1016/j.jpsychires.2021.04.019_bib40 article-title: 30 Years on: how the neurodevelopmental hypothesis of schizophrenia morphed into the developmental risk factor model of psychosis publication-title: Schizophr. Bull. doi: 10.1093/schbul/sbx121 – volume: 280 start-page: 41 issue: 1 year: 2017 ident: 10.1016/j.jpsychires.2021.04.019_bib59 article-title: Alarmins and immunity publication-title: Immunol. Rev. doi: 10.1111/imr.12577 – volume: 14 start-page: 43 issue: 1 year: 2017 ident: 10.1016/j.jpsychires.2021.04.019_bib8 article-title: HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins publication-title: Cell. Mol. Immunol. doi: 10.1038/cmi.2016.34 – volume: 80 start-page: 305 issue: 2–3 year: 2005 ident: 10.1016/j.jpsychires.2021.04.019_bib50 article-title: Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms publication-title: Schizophr. Res. doi: 10.1016/j.schres.2005.04.013 – volume: 113 start-page: E2705 issue: 19 year: 2016 ident: 10.1016/j.jpsychires.2021.04.019_bib25 article-title: IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.1604032113 – volume: 18 start-page: e27 issue: 4 year: 2018 ident: 10.1016/j.jpsychires.2021.04.019_bib45 article-title: Damage-associated molecular patterns in inflammatory diseases publication-title: Immune. Netw. doi: 10.4110/in.2018.18.e27 – volume: 45 start-page: 499 issue: 3 year: 2012 ident: 10.1016/j.jpsychires.2021.04.019_bib23 article-title: HMGB1 in development and diseases of the central nervous system publication-title: Mol. Neurobiol. doi: 10.1007/s12035-012-8264-y – volume: 9 start-page: 2379 year: 2018 ident: 10.1016/j.jpsychires.2021.04.019_bib3 article-title: Pattern recognition receptors and the host cell death molecular machinery publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.02379 – volume: 13 start-page: 24 issue: 1 year: 2013 ident: 10.1016/j.jpsychires.2021.04.019_bib22 article-title: Functions of S100 proteins publication-title: Curr. Mol. Med. doi: 10.2174/156652413804486214 – volume: 13 start-page: 127 year: 2019 ident: 10.1016/j.jpsychires.2021.04.019_bib60 article-title: The role of high mobility group box 1 in ischemic stroke publication-title: Front. Cell. Neurosci. doi: 10.3389/fncel.2019.00127 – volume: 30 start-page: 75 issue: 2 year: 2019 ident: 10.1016/j.jpsychires.2021.04.019_bib30 article-title: [Inflammation and neurodegeneration in patients with early-stageand chronic bipolar disorder] publication-title: Türk PsikiyatriDerg. – volume: 157 start-page: 41 year: 2014 ident: 10.1016/j.jpsychires.2021.04.019_bib7 article-title: A preliminary report of increased plasma levels of IL-33 in bipolar disorder: further evidence of pro-inflammatory status publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2013.12.042 – volume: 7 start-page: 6 year: 2010 ident: 10.1016/j.jpsychires.2021.04.019_bib16 article-title: Serum levels of S100B and NSE proteins in Alzheimer's disease patients publication-title: J. Neuroinflammation doi: 10.1186/1742-2094-7-6 – volume: 2020 start-page: 8465083 year: 2020 ident: 10.1016/j.jpsychires.2021.04.019_bib13 article-title: Alarmins HMGB1, IL-33, S100A7, and S100A12 in psoriasis vulgaris publication-title: Mediat. Inflamm. doi: 10.1155/2020/8465083 – volume: 40 start-page: 167 issue: 1 year: 2019 ident: 10.1016/j.jpsychires.2021.04.019_bib6 article-title: High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease publication-title: Neurol. Sci. doi: 10.1007/s10072-018-3611-z – volume: 8 start-page: 55 issue: 1 year: 2017 ident: 10.1016/j.jpsychires.2021.04.019_bib2 article-title: Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis publication-title: Biomol. Concepts doi: 10.1515/bmc-2016-0026 – volume: 6 start-page: 121 issue: 2 year: 2007 ident: 10.1016/j.jpsychires.2021.04.019_bib64 article-title: Reliability of S100B in predicting severity of central nervous system injury publication-title: Neurocrit. Care doi: 10.1007/s12028-007-0008-x – volume: 77 start-page: 201 year: 2020 ident: 10.1016/j.jpsychires.2021.04.019_bib35 article-title: Schizophrenia-an overview publication-title: JAMA. Psychiatry. doi: 10.1001/jamapsychiatry.2019.3360 – volume: 148 start-page: 168 issue: 2 year: 2019 ident: 10.1016/j.jpsychires.2021.04.019_bib37 article-title: The S100B story: from biomarker to active factor in neural injury publication-title: J. Neurochem. doi: 10.1111/jnc.14574 – volume: 37 start-page: 1 issue: 1 year: 2016 ident: 10.1016/j.jpsychires.2021.04.019_bib29 article-title: Epidemiology and risk factors of schizophrenia publication-title: Neuroendocrinol. Lett. – volume: 81 start-page: 1 issue: 1 year: 2007 ident: 10.1016/j.jpsychires.2021.04.019_bib9 article-title: DAMPs, PAMPs and alarmins: all we need to know about danger publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0306164 – volume: 8 start-page: 475 year: 2017 ident: 10.1016/j.jpsychires.2021.04.019_bib26 article-title: The ST2/IL-33 Axis in immune cells during inflammatory diseases publication-title: Front. Immunol. doi: 10.3389/fimmu.2017.00475 – volume: 65 start-page: 764 year: 2010 ident: 10.1016/j.jpsychires.2021.04.019_bib57 article-title: White blood cell count and C-reactive protein are independent predictors of mortality in the oldest old publication-title: J. Gerontol. A Biol. Sci. Med Sci. doi: 10.1093/gerona/glq004 – volume: 69 start-page: 346 issue: 5 year: 2015 ident: 10.1016/j.jpsychires.2021.04.019_bib58 article-title: Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder publication-title: Nord. J. Psychiatr. doi: 10.3109/08039488.2014.984755 – volume: 9 start-page: 271 year: 2018 ident: 10.1016/j.jpsychires.2021.04.019_bib12 article-title: IL-33/ST2 pathway and galectin-3 as a new analytes in pathogenesis and cardiometabolic risk evaluation in psychosis publication-title: Front. Psychiatr. doi: 10.3389/fpsyt.2018.00271 – volume: 47 start-page: 74 year: 2019 ident: 10.1016/j.jpsychires.2021.04.019_bib33 article-title: Dual faced HMGB1 plays multiple roles in cardiomyocyte senescence and cardiac inflammatory injury publication-title: Cytokine Growth Factor Rev. doi: 10.1016/j.cytogfr.2019.05.009 – volume: 120 start-page: 644 issue: 5 year: 2012 ident: 10.1016/j.jpsychires.2021.04.019_bib36 article-title: The S100B protein in biological fluids: more than a lifelong biomarker of brain distress publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2011.07612.x – volume: 94 start-page: 152118 year: 2019 ident: 10.1016/j.jpsychires.2021.04.019_bib62 article-title: Serum high-sensitivity C-reactive protein levels are positively associated with cognitive impairments in patients with first-episode schizophrenia publication-title: Compr. Psychiatr. doi: 10.1016/j.comppsych.2019.152118 – volume: 95 start-page: 3818 issue: 47 year: 2015 ident: 10.1016/j.jpsychires.2021.04.019_bib63 article-title: [Analysis of the changes of serum high mobility group protein B1 and cytokines in first-episode schizophrenia patients] publication-title: Zhonghua Yixue Zazhi – volume: 6 start-page: 27584 year: 2016 ident: 10.1016/j.jpsychires.2021.04.019_bib28 article-title: Higher plasma S100B concentrations in schizophrenia patients, and dependently associated with inflammatory markers publication-title: Sci. Rep. doi: 10.1038/srep27584 – volume: 91 start-page: 59 year: 2016 ident: 10.1016/j.jpsychires.2021.04.019_bib48 article-title: In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2016.02.018 – year: 2010 ident: 10.1016/j.jpsychires.2021.04.019_bib52 article-title: S100B protein, A damage-associated molecular pattern protein in the brain and heart, and beyond publication-title: Cardiovasc. Psychiatry. Neurol. doi: 10.1155/2010/656481 – volume: 159 start-page: 209 issue: 2 year: 2017 ident: 10.1016/j.jpsychires.2021.04.019_bib53 article-title: A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury publication-title: Acta Neurochir. doi: 10.1007/s00701-016-3046-3 – volume: 151 start-page: 43 issue: 1–3 year: 2013 ident: 10.1016/j.jpsychires.2021.04.019_bib54 article-title: Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis publication-title: Schizophr. Res. doi: 10.1016/j.schres.2013.10.011 – volume: 74 start-page: 96 year: 2017 ident: 10.1016/j.jpsychires.2021.04.019_bib19 article-title: Serum levels of interleukin-33 and its soluble form receptor (sST2) are associated with cognitive performance in patients with schizophrenia publication-title: Compr. Psychiatr. doi: 10.1016/j.comppsych.2017.01.008 – volume: 35 start-page: 5931 issue: 46 year: 2016 ident: 10.1016/j.jpsychires.2021.04.019_bib27 article-title: Damage-associated molecular patterns in cancer: a double-edged sword publication-title: Oncogene doi: 10.1038/onc.2016.104 – volume: 10 start-page: 892 year: 2019 ident: 10.1016/j.jpsychires.2021.04.019_bib39 article-title: Cytokine alterations in schizophrenia: an updated review publication-title: Front. Psychiatr. doi: 10.3389/fpsyt.2019.00892 – volume: 146 start-page: 211 issue: 3 year: 2018 ident: 10.1016/j.jpsychires.2021.04.019_bib4 article-title: High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches publication-title: J. Neurochem. doi: 10.1111/jnc.14450 – volume: 167 start-page: 66 issue: 1–2 year: 2009 ident: 10.1016/j.jpsychires.2021.04.019_bib51 article-title: Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia--original research and meta-analysis publication-title: Psychiatr. Res. doi: 10.1016/j.psychres.2008.01.002 – volume: 198 start-page: 1395 issue: 4 year: 2017 ident: 10.1016/j.jpsychires.2021.04.019_bib44 article-title: Alarmins: feel the stress publication-title: J. Immunol. doi: 10.4049/jimmunol.1601342 |
SSID | ssj0007214 |
Score | 2.4763703 |
Snippet | There is growing evidence that immune/inflammatory processes are related to the etiology of schizophrenia. Danger-/damage-associated molecular patterns... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 380 |
SubjectTerms | Biomarkers HMGB1 IL-33 S100B Schizophrenia sST2 |
Title | Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0022395621002454 https://dx.doi.org/10.1016/j.jpsychires.2021.04.019 https://www.ncbi.nlm.nih.gov/pubmed/33957300 https://www.proquest.com/docview/2524362902 |
Volume | 138 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS-QwEA-iIPcift25fhHBBw-2Z5qkbYJPq6ir3vpwKvgWmjSFFe0udn31b3emH6vCCQs-9mPaZjqd-U3zmwkh-1onWQxHAqfx141WIlA55Dwps056EQPkx_8dg-u4fycv76P7OXLS1sIgrbLx_bVPr7x1s-ew0ebheDjEGl8IbQDveVjNH2JPUCkTtPI_r-80D8hw5LRjOJzdsHlqjtdDTSmGxBYyRR5WTU-x587_Q9RXELQKRWfLZKnBkLRXP-YKmfPFKlkcNLPka-RfD9LVp2FR0oOLv4EQXVre3PIu7Q_Oj8MuTYuM3sBojn_TtKTj0QQJQ3A9rMRHss5zSQHJ0vIjHW-d3J2d3p70g2bthMBJFU6CPEq5d4AGtOdJLlkqsgR8rFJZmABkiMM441apFFPUyLFcYYmqyJnOlYsz58VPMl-MCr9BqMstfKmWSw_h3vLISiEgH7cpy2MrEt0hSasu45rG4ri-xaNpGWQP5l3RBhVtmDSg6A4Jp5LjurnGDDK6fSOmLR4Fd2cgAswgezSV_WRkM0rvtQZg4BvEiZW08KMXOCniEoCAZrxDftWWMR2PwIlQwdjmt-69RX7gVs1R2ybzk-cXvwNoaGJ3K3PfJQu9i6v-9RspYQdF |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwED6NTgJeED9HgQ0j8QBSozm2k9jiqZs2Utb2gXXS3qzYcaROkFZL9_9zbpwA0pAq8Rrnkvhi331nf3cG-KhUVqbYElnll26U5JGsMOYpqLHC8RQhv1_vmM3T_Ep8u06u9-C0y4XxtMpg-1ubvrXW4cpx0Obxern0Ob7o2hDes3i7fygewL6vTpUMYH88ucjnvUHGIEf0RcNRIBB6WprXTcsqxtgWg0UWb-ue-rI793upf6HQrTc6fwpPAowk4_ZLn8Geq5_Dw1nYKH8B38cYsf5c1g35NJlGnI9Ic7lgI5LPvp7EI1LUJbnEDp18JkVD1quN5wzh83wyvufr3DYEwSxp_mTkvYSr87PFaR6F4xMiK2S8iaqkYM4iIFCOZZWgBS8zNLNSlnGGqCGN05IZKQsfpSaWVtJnqfKKqkratLSOv4JBvardayC2MjhZDRMOPb5hiRGcY0huClqlhmdqCFmnLm1DbXF_xMUP3ZHIbvRvRWuvaE2FRkUPIe4l1219jR1kVPdHdJc_ihZPoxPYQfZLL_vXONtR-kM3ADROQ7-3UtRudYc3JUwgFlCUDeGgHRl9f7jfC-WUvvmvd7-HR_liNtXTyfziLTz2LS1l7R0MNrd37hDB0cYchcH_CypJCfY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alarmins+%28IL-33%2C+sST2%2C+HMGB1%2C+and+S100B%29+as+potential+biomarkers+for+schizophrenia&rft.jtitle=Journal+of+psychiatric+research&rft.au=Koz%C5%82owska%2C+El%C5%BCbieta&rft.au=Brzezi%C5%84ska-B%C5%82aszczyk%2C+Ewa&rft.au=Agier%2C+Justyna&rft.au=Wysoki%C5%84ski%2C+Adam&rft.date=2021-06-01&rft.eissn=1879-1379&rft.volume=138&rft.spage=380&rft_id=info:doi/10.1016%2Fj.jpsychires.2021.04.019&rft_id=info%3Apmid%2F33957300&rft.externalDocID=33957300 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3956&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3956&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3956&client=summon |